• Home
  • When destiny doesn't pan out: Implications for the treatment of sarcomas after the agnostic approval of trastuzumab deruxtecan.

When destiny doesn't pan out: Implications for the treatment of sarcomas after the agnostic approval of trastuzumab deruxtecan.

Author List
Schulte BC, Hwang C, Horvai AE, Olivier T
Publication
Cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/539030194
Publication Year
2024
PubMed ID
39182174
Publication Title
Schulte BC, Hwang C, Horvai AE, Olivier T. When destiny doesn't pan out: Implications for the treatment of sarcomas after the agnostic approval of trastuzumab deruxtecan. Cancer. 2024 Dec 01; 130(23):4020-4024.